Bionomics (BNOX) has released an update.
Bionomics Limited, an Australian biotech firm, has entered into a Securities Purchase Agreement with select investors to sell Restricted ADSs, Accompanying Warrants, and Pre-Funded Warrants, leveraging exemptions from registration under the Securities Act of 1933. This strategic move aims to facilitate the company’s expansion by providing certain registration rights and enabling the trading of shares on the Nasdaq Global Market. The agreement underscores Bionomics’ commitment to growth and investor confidence in its future.
For further insights into BNOX stock, check out TipRanks’ Stock Analysis page.
